Check Out Our Digital RESI September Panel Line Up!

13 Aug

By Claire Jeong, Vice President of Investor Research, Asia BD, LSN

claire

With one month left until the next Digital Redefining Early Stage Investments (RESI) September Conference (September 14-16), we are very excited to highlight some of the key speakers who will be contributing to our virtual panels.

These speakers are all investors and strategic partners who actively invest in and work with early-stage life science and healthcare companies, with diverse interests within therapeutics, medical devices, diagnostics, and digital health.

Digital RESI September registrants get to hear from the leading industry experts about their investment strategies and differentiated approaches, recent investments and areas of interest, and more.

Here are some of the panelists joining us:


Jun Deng
Investment Partner
Joyance Partners

Prathna Ramesh
Executive Director
Maple Leaf Angels (MLA)

Nancy Torres Kaufman
CEO
Beacon Capital

Steve Yoder
Vice President, Business Development
Taiho Oncology Inc

Duncan Young
Director, Search and Evaluation Oncology, BD&L
AstraZeneca

Barbara Lavery
Chief Program Officer
Alliance for Cancer Gene Therapy

Mark Krul
Partner
Aglaia Oncology Funds

Weiyong Sun
Senior Director, Specialty Medicine Search & Evaluation
Daiichi Sankyo

Fiona Mack
Head of JLABS TMCx
Johnson & Johnson Innovation

Chris Haskell
VP, Head of West Coast Innovation Center
Bayer

Yao Li Ho
Senior Director of Business Development
LYFE Capital

Haolin Sung
Managing Partner
Chaperone Investment

Christina Salys
Sr. Mgr. New Business Development
Intuitive Surgical

Rupert Winckler
Head of EMEA New Business Development
Olympus Corporation

William Dai
Founding Partner
ShangBay Capital

Benedikt Luhmann
Principal – Healthcare
VI Partners

Norm Gitis
Founder, Managing Partner
Lymo Ventures

Paul Larkin
Manager, Research Innovation
Crohn’s and Colitis Foundation

Michael Cole
Founder and General Partner
Global Neurohealth Ventures

Lore Gruenbaum
Vice President, Therapy Acceleration Program
Leukemia & Lymphoma Society (LLS)

Kuldip Dave
Vice President of Research
ALS Association

Chris Penland
VP BioPharma Programs
Cystic Fibrosis Foundation

Mayank Taneja
Director of Venture Investments
OSF Healthcare Ventures

Cyril Philip
Principal
Providence Ventures

Rajesh Aggarwal
Executive Vice President
Jefferson Strategic Ventures

Linda Maxwell
Director
Biomedical Zone

Ron Paliwoda
Founder and President
Paliwoda Group

Marcia Dawood
Managing Partner
Individual Angel

Merom Klein
Entrepreneur Mentor
Keiretsu Forum

Laura Davis
Managing Director
Golden Seeds

Rob Manning
Chairman
Cherrystone Angel Group

Sascha Berger
Partner
TVM Capital Life Science

Haruhiko Sugino
Director, Global Business Development
Otsuka Pharmaceuticals

Bibhash Mukhopadhyay
Principal
New Enterprise Associates

Jayson Punwani
Senior Partner
Takeda Ventures

Scott Weiner
Partner
Amzak Health

Roy Wiesner
Managing Director
aMoon Fund

Robert Garber
Partner
7wire Ventures

Evan Cohen
Associate Principal, Strategic Investing
Healthbox

Ben Evans
Investment Director
InHealth Ventures

Netalie Nadivi
Partner
TriVentures

Rick Jones
Partner
BioAdvance

Katherine Hill Ritchie
Director
Nottingham Spirk Family Office

Mark Ralph
Executive Director
Boehringer Ingelheim Venture Fund

Please contact RESI@lifesciencenation.com if you are interested in any speaking opportunities!

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: